Although histological and immunohistochemical analyses have been accepted as the reference standard, identification of the relationship between DESCT quantitative measurements and KRAS status could help determine the molecular categories of lung adenocarcinoma. This evidence concerns the gene KRAS and lung adenocarcinoma.